MarketBeat Instant News Alerts

CG Oncology logo with Healthcare background

CG Oncology (NASDAQ:CGON) Earns Buy Rating from Truist Financial

Truist Financial restated a "buy" rating and issued a $100.00 price objective (up from $85.00) on shares of CG Oncology in a research note on Tuesday.

NASDAQ:CGON
Read CG Oncology (NASDAQ:CGON) Earns Buy Rating from Truist Financial
Expeditors International of Washington logo with Industrials background

Expeditors International of Washington (NASDAQ:EXPD) Price Target Raised to $200.00

Barclays increased their price target on shares of Expeditors International of Washington from $175.00 to $200.00 and gave the stock an "underweight" rating in a report on Tuesday.

NASDAQ:EXPD
Read Expeditors International of Washington (NASDAQ:EXPD) Price Target Raised to $200.00
IDEAYA Biosciences logo with Healthcare background

IDEAYA Biosciences (NASDAQ:IDYA) Given "Outperform" Rating at Royal Bank Of Canada

Royal Bank Of Canada reissued an "outperform" rating and issued a $45.00 target price on shares of IDEAYA Biosciences in a report on Tuesday.

NASDAQ:IDYA
Read IDEAYA Biosciences (NASDAQ:IDYA) Given "Outperform" Rating at Royal Bank Of Canada
BILL logo with Technology background

BILL (NYSE:BILL) Given New $58.00 Price Target at Truist Financial

Truist Financial raised their price target on shares of BILL from $50.00 to $58.00 and gave the company a "hold" rating in a report on Tuesday.

NYSE:BILL
Read BILL (NYSE:BILL) Given New $58.00 Price Target at Truist Financial
Ardent Health logo with Healthcare background

Ardent Health (NYSE:ARDT) Stock Gets Price Target Bump from Truist Financial

Truist Financial raised their price objective on shares of Ardent Health from $13.00 to $22.00 and gave the stock a "buy" rating in a research report on Tuesday.

NYSE:ARDT
Read Ardent Health (NYSE:ARDT) Stock Gets Price Target Bump from Truist Financial
Bausch + Lomb logo with Healthcare background

Bausch + Lomb (NYSE:BLCO) Stock Price Expected to Rise, Barclays Analyst Says

Barclays boosted their price objective on shares of Bausch + Lomb from $24.00 to $27.00 and gave the company an "overweight" rating in a report on Tuesday.

NYSE:BLCO
Read Bausch + Lomb (NYSE:BLCO) Stock Price Expected to Rise, Barclays Analyst Says

Trending News

All MarketBeat Instant News Alerts

Affirm logo with Finance background

Truist Financial Has Lowered Expectations for Affirm (NASDAQ:AFRM) Stock Price

NASDAQ:AFRM
Read Truist Financial Has Lowered Expectations for Affirm (NASDAQ:AFRM) Stock Price
Eli Lilly and Company logo with Healthcare background

Eli Lilly and Company's (LLY) "Outperform" Rating Reiterated at Royal Bank Of Canada

NYSE:LLY
Read Eli Lilly and Company's (LLY) "Outperform" Rating Reiterated at Royal Bank Of Canada
Community Health Systems logo with Healthcare background

Community Health Systems (NYSE:CYH) Stock Price Target Lowered at Royal Bank Of Canada

NYSE:CYH
Read Community Health Systems (NYSE:CYH) Stock Price Target Lowered at Royal Bank Of Canada

Blackstone Digital Infrastructure Trust (NYSE:BXDC) Stock Price Target Raised at Royal Bank Of Canada

NYSE:BXDC
Read Blackstone Digital Infrastructure Trust (NYSE:BXDC) Stock Price Target Raised at Royal Bank Of Canada
American Homes 4 Rent logo with Real Estate background

American Homes 4 Rent (NYSE:AMH) Earns Market Outperform Rating from Citizens Jmp

NYSE:AMH
Read American Homes 4 Rent (NYSE:AMH) Earns Market Outperform Rating from Citizens Jmp
NIKE logo with Consumer Discretionary background

NIKE (NYSE:NKE) Issues FY 2031 Earnings Guidance

NYSE:NKE
Read NIKE (NYSE:NKE) Issues FY 2031 Earnings Guidance
Acrivon Therapeutics logo with Healthcare background

Acrivon Therapeutics (NASDAQ:ACRV) Stock Keeps "Market Outperform" Rating at Citizens Jmp

NASDAQ:ACRV
Read Acrivon Therapeutics (NASDAQ:ACRV) Stock Keeps "Market Outperform" Rating at Citizens Jmp
Intuit logo with Technology background

Intuit (NASDAQ:INTU) Given New $330.00 Price Target at Wells Fargo & Company

NASDAQ:INTU
Read Intuit (NASDAQ:INTU) Given New $330.00 Price Target at Wells Fargo & Company
Microbot Medical logo with Healthcare background

Microbot Medical (NASDAQ:MBOT) Price Target Cut to $2.00 by Analysts at Citizens Jmp

NASDAQ:MBOT
Read Microbot Medical (NASDAQ:MBOT) Price Target Cut to $2.00 by Analysts at Citizens Jmp
Forgent Power Solutions logo with Industrials background

Forgent Power Solutions (NYSE:FPS) Stock Price Target Cut by Wells Fargo & Company

NYSE:FPS
Read Forgent Power Solutions (NYSE:FPS) Stock Price Target Cut by Wells Fargo & Company
Grindr logo with Communication Services background

Grindr (NYSE:GRND) Stock Gets Price Target Boost from Citizens Jmp

NYSE:GRND
Read Grindr (NYSE:GRND) Stock Gets Price Target Boost from Citizens Jmp
GXO Logistics logo with Industrials background

GXO Logistics (NYSE:GXO) Price Target Raised to $75.00

NYSE:GXO
Read GXO Logistics (NYSE:GXO) Price Target Raised to $75.00
Illumina logo with Healthcare background

Illumina Sees Strong Clinical Demand, but Research Recovery Remains in Question

NASDAQ:ILMN
Read Illumina Sees Strong Clinical Demand, but Research Recovery Remains in Question
Tencent Music Entertainment Group logo with Communication Services background

Tencent Music Entertainment Group Q3 Earnings Call Highlights

NYSE:TME
Read Tencent Music Entertainment Group Q3 Earnings Call Highlights
Exp World logo with Real Estate background

Exp World (NASDAQ:AGNT) Stock Gets Price Target Reduction from StoneX

NASDAQ:AGNT
Read Exp World (NASDAQ:AGNT) Stock Gets Price Target Reduction from StoneX
The Pennant Group logo with Healthcare background

The Pennant Group (NASDAQ:PNTG) Stock Gets Price Target Increase from Wells Fargo & Company

NASDAQ:PNTG
Read The Pennant Group (NASDAQ:PNTG) Stock Gets Price Target Increase from Wells Fargo & Company
VEON logo with Communication Services background

VEON (NASDAQ:VEON) Stock Gets Price Target Boost from StoneX

NASDAQ:VEON
Read VEON (NASDAQ:VEON) Stock Gets Price Target Boost from StoneX
Cardinal Health logo with Healthcare background

Cardinal Health (NYSE:CAH) Given New $321.00 Price Target at Wells Fargo & Company

NYSE:CAH
Read Cardinal Health (NYSE:CAH) Given New $321.00 Price Target at Wells Fargo & Company
Church & Dwight logo with Consumer Staples background

Wells Fargo & Company Forecasts Strong Price Appreciation for Church & Dwight (NYSE:CHD) Stock

NYSE:CHD
Read Wells Fargo & Company Forecasts Strong Price Appreciation for Church & Dwight (NYSE:CHD) Stock
Cencora logo with Healthcare background

Wells Fargo & Company Issues Positive Forecast for Cencora (NYSE:COR) Stock Price

NYSE:COR
Read Wells Fargo & Company Issues Positive Forecast for Cencora (NYSE:COR) Stock Price
Perspective Therapeutics logo with Healthcare background

Perspective Therapeutics (NYSEAMERICAN:CATX) Director Purchases 15,000 Shares of Company Stock

NYSEAMERICAN:CATX
Read Perspective Therapeutics (NYSEAMERICAN:CATX) Director Purchases 15,000 Shares of Company Stock
Radcom logo with Technology background

Radcom (NASDAQ:RDCM) Stock: Insider Sami Totah Sells 2,899 Shares

NASDAQ:RDCM
Read Radcom (NASDAQ:RDCM) Stock: Insider Sami Totah Sells 2,899 Shares
Lineage Cell Therapeutics logo with Healthcare background

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) CEO Brian Culley Purchases 40,500 Shares of Company Stock

NYSEAMERICAN:LCTX
Read Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) CEO Brian Culley Purchases 40,500 Shares of Company Stock
Scotts Miracle-Gro logo with Materials background

Scotts Miracle-Gro (NYSE:SMG) Stock: Insider Peter Shumlin Sells 3,716 Shares

NYSE:SMG
Read Scotts Miracle-Gro (NYSE:SMG) Stock: Insider Peter Shumlin Sells 3,716 Shares

Featured Articles and Offers

Alert Categories

All Alerts